Cell membranes, immune function and the Global Constraint Rule

What does membrane research tell us about immune function?

A 2026 study in Nature Chemical Biology found that membrane order helped distinguish immune-cell states and groups of natural killer cells with different functions in laboratory tests.[1]

For MediBalans, this offers a possible measurement for testing a membrane-related Global Constraint Rule (GCR) hypothesis. The study did not test or validate GCR, establish that membrane order caused the functional differences, or demonstrate a diagnostic test or treatment for patients.

What is membrane order?

Membrane order describes how lipids are organised in a cell membrane. In this study, researchers measured it with the fluorescent probe Pro12A and flow cytometry. The measurement added information about immune-cell states beyond conventional surface markers.[1]

Why measure membranes when investigating impaired function?

When we investigate why a biological system is functioning poorly, the question that interests us is what is preventing it from doing its work. A measurement becomes useful when it helps us understand that limitation, explains something the other findings have left unresolved, or changes what we should investigate next. This is the question I bring to a recent paper in Nature Chemical Biology, which examines the relationship between the physical state of immune-cell membranes and the behaviour of the cells themselves.[1]

How was membrane order linked to immune-cell function?

Andronico and colleagues measured membrane order, a property describing the organization of membrane lipids, using a fluorescent probe called Pro12A alongside flow cytometry. Their comparison included 14 healthy donors, 14 people with long COVID and five with chronic lymphocytic leukaemia. The membrane measurement added information about immune-cell states beyond conventional surface markers.[1]

The researchers also separated natural killer cells according to membrane order. Those selected for lower order migrated faster, while those selected for higher order showed greater tumour-cell killing and survival in laboratory assays. There is a detail here that deserves attention: after 24 hours in culture, the membrane-order differences converged. The authors therefore interpreted the original measurement as an indicator of functional cell state, rather than demonstrating that membrane order directly determined the subsequent behaviour.[1]

How does membrane research relate to the Global Constraint Rule?

For me, this is where the paper becomes particularly relevant to the Global Constraint Rule, the reasoning framework we use at MediBalans. Within GCR, we ask which constraint is most limiting a system at a particular point, and whether addressing it allows function to improve. The proposed framework considers gut and microbiome, transport, cellular membranes, mitochondria, and genetic and methylation machinery. The membrane is already part of that clinical reasoning, so research that allows its state to be examined more precisely gives us a specific question to pursue.

Does this study validate the Global Constraint Rule?

No. The study did not test GCR, establish our proposed sequence of constraints, or show that changing membrane order restores health. My interpretation is that it provides a possible measurement around which a membrane-related GCR hypothesis could be built and tested. That is a meaningful connection, provided we describe it at the level the evidence supports.

How could a membrane-related GCR hypothesis be tested?

A constraint-based explanation should tell us what we expect to happen. If we believe a particular membrane property is limiting a cell's function, we should specify the function, measure the proposed limitation, and predict what will change when we address it. Without that prediction, almost any finding can be fitted into the explanation afterwards, and the framework loses its ability to guide an investigation.

I would therefore begin with a controlled experiment in which the suspected membrane limitation and the functional outcome are measured together. Researchers would need an intervention that changes the property of interest, appropriate comparison conditions, and a way to distinguish that effect from changes in cell viability or other processes. If the membrane measurement changes but function does not improve, we would need to reconsider whether we had identified the relevant limitation. If both improve, we would still need to establish how the two are connected.

Could another constraint become limiting?

The next step would examine a further prediction of GCR: whether relieving one constraint makes another become limiting. This should be something we can identify prospectively. An explanation that names a new constraint only after every unsuccessful intervention would be difficult to test. A useful model should help us anticipate the response, define what would count against it, and revise our reasoning when the observations disagree.

Can these findings explain a patient’s persistent symptoms?

For a patient reading this because they are looking for an explanation for persistent symptoms, I would keep the clinical interpretation equally specific. We would need evidence connecting the proposed measurement to their condition before attributing their symptoms to membrane dysfunction. We would also need separate evidence for any treatment recommendation. The same applies to tests already used in clinical practice: their relevance cannot be assumed simply because they involve cells or nutrients.

Before introducing a new measurement into care, I would want to know how reliably it can be repeated, what it adds to the assessment we already have, and whether decisions based on it improve outcomes for patients. These are the questions that determine its clinical value. An additional result should help us make a better decision, with a clear account of what we would do differently because we have it.

What is the next research step for MediBalans?

For MediBalans, the next step is to turn this connection into a defined research question: under which conditions, if any, does a membrane property become a limiting constraint, and what evidence would demonstrate that relieving it improves function? Answering that would give the membrane component of GCR a firmer experimental basis and allow our interpretation to develop alongside the evidence.